Communiqués Arcturus Therapeutics Holdings Inc.

Actions

ARCT

US03969T1097

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 09/10/2026			Varia. 5j.	Varia. 1 janv.
13,74 ^USD	+6,76%		+5,45%	+124,14%

24/09	Les actions d’Arcturus Therapeutics progressent après les données sur le déficit en OTC et le relèvement de Citigroup	MT
24/09	Arcturus Therapeutics Holdings Inc. : Citigroup revoit son opinion à la hausse	ZM

Communiqués

24/09	Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0 Next-Generation mRNA Delivery Platform	AQ
23/09	Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform	BU
18/09	Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform	BU
31/08	Arcturus Therapeutics to Participate in Upcoming Investor Conferences	BU
07/08	Arcturus Therapeutics : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)	PU
06/08	Arcturus Therapeutics: Q2 Earnings Snapshot	AQ
06/08	Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress	BU
28/07	Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026	BU
20/07	Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference	BU
02/07	Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis	BU
26/05	Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference	BU
08/05	Arcturus Therapeutics : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
07/05	Arcturus Therapeutics: Q1 Earnings Snapshot	AQ
07/05	Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress	BU
27/04	Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026	BU
05/03	Arcturus Therapeutics to Attend Upcoming Investor Conference	BU
03/03	Arcturus Therapeutics: Q4 Earnings Snapshot	AQ
03/03	Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress	BU
17/02	Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026	BU
08/01	Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference	BU
24/11	Arcturus Therapeutics to Attend Upcoming Investor Conference	BU
10/11	Arcturus Therapeutics: Q3 Earnings Snapshot	AQ
10/11	Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress	BU
04/11	Arcturus Therapeutics to Attend Upcoming Investor Conferences	BU
28/10/25	Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025	BU